CALB2 and asbestosis: Data on both SMRP and calretinin levels were available in a subset of 416 patients: 68 MM patients, 106 subjects with asbestosis, 184 subjects with pleural plaques and 58 occupationally asbestos-exposed subjects that did not develop any asbestos-related diseases.